BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 17986328)

  • 1. Myasthenia gravis.
    Juel VC; Massey JM
    Orphanet J Rare Dis; 2007 Nov; 2():44. PubMed ID: 17986328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ocular aspects of myasthenia gravis.
    Barton JJ; Fouladvand M
    Semin Neurol; 2000; 20(1):7-20. PubMed ID: 10874773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pearls: myasthenia.
    Benatar M
    Semin Neurol; 2010 Feb; 30(1):35-7. PubMed ID: 20127579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repetitive nerve stimulation and single-fiber electromyography in the evaluation of patients with suspected myasthenia gravis or Lambert-Eaton myasthenic syndrome: Review of recent literature.
    Chiou-Tan FY; Gilchrist JM
    Muscle Nerve; 2015 Sep; 52(3):455-62. PubMed ID: 26109387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoimmune disorders of neuromuscular transmission.
    Mahadeva B; Phillips LH; Juel VC
    Semin Neurol; 2008 Apr; 28(2):212-27. PubMed ID: 18351523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MuSK not MNGIE: Atypical MuSK-antibody myasthenia presenting as a genetic disorder.
    Thebault S; Gibbs E; Bourque P; McKim D; Rakhra K; Breiner A; Frykman H; Warman-Chardon J
    Neuromuscul Disord; 2021 Dec; 31(12):1279-1281. PubMed ID: 34690051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myasthenia gravis: signs, symptoms, diagnosis, immunology, and current therapy.
    Scheife RT; Hills JR; Munsat TL
    Pharmacotherapy; 1981; 1(1):39-54. PubMed ID: 6927602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis.
    Evoli A; Tonali PA; Padua L; Monaco ML; Scuderi F; Batocchi AP; Marino M; Bartoccioni E
    Brain; 2003 Oct; 126(Pt 10):2304-11. PubMed ID: 12821509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Myasthenia gravis].
    Fleury MC; Tranchant C
    Rev Prat; 2008 Dec; 58(20):2217-24. PubMed ID: 19209651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efgartigimod improves muscle weakness in a mouse model for muscle-specific kinase myasthenia gravis.
    Huijbers MG; Plomp JJ; van Es IE; Fillié-Grijpma YE; Kamar-Al Majidi S; Ulrichts P; de Haard H; Hofman E; van der Maarel SM; Verschuuren JJ
    Exp Neurol; 2019 Jul; 317():133-143. PubMed ID: 30851266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pseudoparalytic myasthenia gravis. Diagnostic and therapeutic aspects in 60 separate cases].
    Mumenthaler M; Lütschg J
    Schweiz Arch Neurol Neurochir Psychiatr; 1976; 118(1):23-56. PubMed ID: 981976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myasthenia Gravis: Unusual Presentations and Diagnostic Pitfalls.
    Rodolico C; Parisi D; Portaro S; Biasini F; Sinicropi S; Ciranni A; Toscano A; Messina S; Musumeci O; Vita G; Girlanda P
    J Neuromuscul Dis; 2016 Aug; 3(3):413-418. PubMed ID: 27854225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myasthenia and related disorders of the neuromuscular junction.
    Spillane J; Beeson DJ; Kullmann DM
    J Neurol Neurosurg Psychiatry; 2010 Aug; 81(8):850-7. PubMed ID: 20547629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and scientific aspects of muscle-specific tyrosine kinase-related myasthenia gravis.
    Reddel SW; Morsch M; Phillips WD
    Curr Opin Neurol; 2014 Oct; 27(5):558-65. PubMed ID: 25159928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myasthenia gravis with a paraneoplastic marker.
    Leavitt JA
    J Neuroophthalmol; 2000 Jun; 20(2):102-5. PubMed ID: 10870923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective response to rituximab in a young child with MuSK-associated myasthenia gravis.
    Govindarajan R; Iyadurai SJ; Connolly A; Zaidman C
    Neuromuscul Disord; 2015 Aug; 25(8):651-2. PubMed ID: 25998611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pediatric Myasthenia Gravis.
    Peragallo JH
    Semin Pediatr Neurol; 2017 May; 24(2):116-121. PubMed ID: 28941526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Myasthenia, from the internist's point of view].
    Eymard B
    Rev Med Interne; 2014 Jul; 35(7):421-9. PubMed ID: 24112993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myasthenia gravis.
    Silvestri NJ; Wolfe GI
    Semin Neurol; 2012 Jul; 32(3):215-26. PubMed ID: 23117946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myasthenia and the neuromuscular junction.
    Gilhus NE
    Curr Opin Neurol; 2012 Oct; 25(5):523-9. PubMed ID: 22892950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.